Involvement of Intracellular pH in Vascular Insulin Resistance

Author(s): Marco A. Ramirez*, Ana R. Beltran, Jorge E. Araya, Marcelo Cornejo, Fernando Toledo, Gonzalo Fuentes, Luis Sobrevia*.

Journal Name: Current Vascular Pharmacology

Volume 17 , Issue 5 , 2019

Become EABM
Become Reviewer

Abstract:

The maintenance of the pH homeostasis is maintained by several mechanisms including the efflux of protons (H+) via membrane transporters expressed in almost all mammalian cells. Along these membrane transporters the sodium/H+ exchangers (NHEs), mainly NHE isoform 1 (NHE1), plays a key role in this phenomenon. NHE1 is under modulation by several environmental conditions (e.g. hyperglycaemia, protein kinase C activity) as well as hormones, including insulin. NHE1 activation causes intracellular alkalization in human endothelial cells leading to activation of the endothelial nitric oxide synthase (eNOS) to generate NO. Intracellular alkalization is a phenomenon that also results in upregulation of the glucose transporter GLUT4 in cells that are responsive to insulin. A reduction in the removal of the extracellular D-glucose is seen in states of insulin resistance, such as in diabetes mellitus and obesity. Since insulin is a potent activator of eNOS in human endothelium, therefore causing vasodilation, and its vascular effect is reduced in insulin resistance it is likely that a defective signal to activate NHE1 in insulin target cells is expected. This phenomenon results in lower redistribution and activation of GLUT4 leading to reduced uptake of D-glucose and hyperglycaemia. The general concept of a role for NHE1, and perhaps other NHEs isoforms, in insulin resistance in the human vasculature is proposed.

Keywords: pH, insulin resistance, insulin, endothelium, diabetes, human, glucose.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 17
ISSUE: 5
Year: 2019
Page: [440 - 446]
Pages: 7
DOI: 10.2174/1570161116666180911104012
Price: $95

Article Metrics

PDF: 13